This study aims to better understand low blood sugar (hypoglycemia) in people with Type 1 Diabetes (T1D) using wearable technology. Up to 20 participants will wear a continuous glucose monitor (CGM) and a smartwatch for four weeks to collect information on blood sugar levels, heart rate, and sleep. Researchers will also measure hormone levels during a special procedure called a hyperglycemic clamp, where your blood sugar is carefully controlled. The main goal is to create a way to identify people with T1D who are at higher risk for hypoglycemia using data from these wearable devices. This could help doctors better manage your care.

Study design

This is a single-site study involving up to 20 participants with Type 1 Diabetes.

What's involved

You would wear a continuous glucose monitor (CGM) and a smartwatch for 4 weeks, and participate in a hyperglycemic clamp procedure. You would also have blood pressure monitoring, vascular tests, and blood draws before and after the clamp.

Compensation

Not stated in the trial record.

Follow-up

You will be monitored for 4 weeks before the hypoglycemic clamp and 1 week after.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.